Kytopen
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
750 Main St, Cambridge, Massachusetts, 0...Phone Number
(617) 299-1688Website
www.kytopen.comRevenue
$6.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Kytopen
Kytopen is a biotechnology company that develops advanced non-viral cell engineering and gene delivery technologies to support the development and manufacturing of next-generation cell therapies. Its proprietary Flowfect platform enables efficient delivery of genetic materials such as DNA, mRNA, and gene-editing tools into living cells using a scalable and continuous flow process. The company focuses on improving cell therapy research and production by making cell modification faster, more consistent, and more suitable for large-scale biomanufacturing. Kytopen works with researchers and biotech organizations to enhance therapeutic development and streamline complex laboratory workflows through innovative engineering solutions.Explore more
Kytopen Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kytopen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Kytopen has new funding data
Congratulate Masked Content for being promoted to Masked Content at Kytopen
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Kytopen recently announced quarterly report
Check out if Kytopen is spiking on competitors!
Kytopen, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Kytopen had a recent Job posting/layoffs
Product Launch: Get notified when Kytopen launches new products
Check if Kytopen has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Kytopen
Find 2 more new buyers
Compare Similar Companies to Kytopen
Compare insights from companies similar to Kytopen, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kytopen is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kytopen is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kytopen.
Kytopen financials insights
Gather financial insights about Kytopen, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$3.6M
2021
Series A
$30M
Kytopen Tech Stack
A closer look at the technologies used by Kytopen
Most Recent Scoops
Funding
Kytopen has secured an undisclosed amount in Series B funding from investor Telegraph Hill Partners.
Funding
Person-Based
Funding
Project
Spending/Investment, Funding
Person-Based
Person-Based
Kytopen News & Media
Kytopen Expands Commercialization Efforts and Board of Directors Following Series B Investment Led by Telegraph Hill Partners
CAMBRIDGE, Mass. and SAN FRANCISCO, April 7, 2026 /PRNewswire/ -- Kytopen Corp., a leader in non-viral, continuous flow cellular engineering, today announced a Series B financing led by Telegraph Hill Partners, with participation from existing investors. The funding will accelerate...Kytopen and Excellos Explore New Pathways to Non-Viral Cell Therapy Manufacturing
Collaboration will investigate how continuous flow cellular engineering and donor-to-dose manufacturing expertise may advance scalable, non-viral processes for next-generation cell therapies. CAMBRIDGE, Mass. and SAN DIEGO, Nov. 12, 2025 /PRNewswire/ -- Kytopen Corp., a leader in...Kytopen Announces Collaboration with BlueWhale Bio to Revolutionize Cell Therapy Manufacturing
Kytopen and BlueWhale Bio join forces to develop non-viral cell therapy manufacturing workflow. BlueWhale Bio's Synecta™ cell-derived nanoparticles (CDNPs) technology mimics the immune system's natural T-cell priming ex vivo and are built to scale, while Kytopen's Flowfect® continuous...Kytopen Elects Industry Veterans to Board, Further Demonstrating its Commitment to Enabling Advanced Engineered Cell Therapy Workflows
Kytopen appoints new board of directors as part of its commercial expansion of the Flowfect Tx® GMP cellular engineering platform. Industry veteran Henry Hebel joins Kytopen's board bringing operational expertise from Aldevron. Joe Gentile, recognized life sciences leader and former board...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Kytopen
Sign Up For FreeTo access detailed company insights
Kytopen is a biotechnology company that develops advanced non-viral cell engineering and gene delivery technologies to support the development and manufacturing of next-generation cell therapies. Its proprietary Flowfect platform enables efficient delivery of genetic materials such as DNA, mRNA, and gene-editing tools into living cells using a scal... Read More
